CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $370,000 | +138.7% | 310,123 | +259.6% | 0.00% | – |
| Q2 2022 | $155,000 | -37.8% | 86,243 | +35.9% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | -61.7% | 63,476 | +75.4% | 0.00% | -71.4% |
| Q4 2018 | $650,000 | -23.2% | 36,184 | +25.7% | 0.01% | +75.0% |
| Q3 2018 | $846,000 | -44.4% | 28,794 | +55.1% | 0.00% | -94.4% |
| Q3 2017 | $1,522,000 | +163.8% | 18,567 | +202.3% | 0.07% | +184.0% |
| Q2 2017 | $577,000 | -84.4% | 6,141 | -92.6% | 0.02% | +4.2% |
| Q4 2016 | $3,687,000 | -38.3% | 83,014 | -49.9% | 0.02% | -42.9% |
| Q3 2016 | $5,975,000 | +691.4% | 165,737 | +1919.2% | 0.04% | +366.7% |
| Q3 2015 | $755,000 | +257.8% | 8,208 | +76.8% | 0.01% | +200.0% |
| Q3 2014 | $211,000 | – | 4,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,688,000 | 4.31% |
| Palo Alto Investors LP | 4,361,411 | $29,440,000 | 1.77% |
| Healthcare Value Capital, LLC | 100,000 | $675,000 | 1.72% |
| SECTOR GAMMA AS | 353,085 | $2,383,000 | 0.49% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $10,800,000 | 0.47% |
| Spark Investment Management LLC | 13,700 | $92,000 | 0.34% |
| 361 CAPITAL LLC | 106,204 | $717,000 | 0.34% |
| Ikarian Capital, LLC | 476,900 | $3,219,000 | 0.26% |
| Virtus ETF Advisers LLC | 79,177 | $534,000 | 0.25% |
| Vigilare Wealth Management | 34,500 | $233,000 | 0.24% |